Brief: Cyclacel Pharmaceuticals To Present Preliminary Data From The Phase 1/2 Clinical Trial Of Oral Fadraciclib At The 34Th Eortc-Nci-Aacr Symposium

Bio Green Med Solution

13/10/2022 14:21

Oct 13 (Reuters) - Cyclacel Pharmaceuticals Inc
 CYCC.O :
    * CYCLACEL PHARMACEUTICALS TO PRESENT PRELIMINARY DATA FROM
THE
PHASE 1/2 CLINICAL TRIAL OF ORAL FADRACICLIB AT THE 34TH
EORTC-NCI-AACR SYMPOSIUM

Source text for Eikon:  ID:nGNX8wgrS6 
Further company coverage:  CYCC.O 
 ((Reuters.Briefs@thomsonreuters.com;))